PRKCQ and glioblastoma: In conclusion, we identified and verified a five immune-related lncRNA signature (AC046143.1, AC021054.1, AC080112.1, MIR222HG, and PRKCQ-AS1) which had independent prognostic value for patients with glioblastoma.